Author

Marie Lequoy

Observed names: LEQUOY, Marie, Lequoy, Marie, M. Lequoy, M., Lequoy

Institutions: Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre de Recherche Saint-Antoine, Fondation pour l’innovation en Cadiométabolisme et Nutrition

ORCID: 0000-0001-8836-3487

Observed ORCID: 0000-0001-8836-3487

OpenAlex ID: A5057385196

Lactate and Venoarterial Carbon Dioxide Difference/Arterial-Venous Oxygen Difference Ratio, but Not Central Venous Oxygen Saturation, Predict Increase in Oxygen Consumption in Fluid Responders*

2013 · Xavier Monnet, Florence Julien, et al. · Critical Care Medicine · 255

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

2023 · Qinghe Zeng, Christophe Klein, et al. · The Lancet Oncology · 129

PDF

Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

2015 · Hamza Chettouh, Marie Lequoy, et al. · Liver International · 115

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

2023 · Julien Calderaro, Narmin Ghaffari Laleh, et al. · Nature Communications · 84

PDF

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

2020 · Giuliana Amaddeo, Raffaele Brustia, et al. · JHEP Reports · 78

PDF

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

2019 · Angélique Gougelet, Chiara Sartor, et al. · Gastroenterology · 51

Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

2022 · Julien Calderaro, Luca Di Tommaso, et al. · Journal of Hepatology · 38

PDF

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

2022 · Elia Gigante, Christian Hobeika, et al. · Liver Cancer · 32

PDF

2024 · Carole Vitellius, Elvire Desjonqueres, et al. · JHEP Reports · 31

Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting

2023 · Manon Falette-Puisieux, Jean-Charles Nault, et al. · Therapeutic Advances in Medical Oncology · 24

PDF

HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: A review

2013 · Constance Thibault, Wassim Khodari, et al. · Critical Reviews in Oncology/Hematology · 23

Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features

2019 · Eva Benabou, Zeina Salamé, et al. · Cancer Letters · 21

PDF

Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis

2016 · Marie Lequoy, Christèle Desbois‐Mouthon, et al. · Histopathology · 15

Sarcoidosis Lung Nodules in Colorectal Cancer Follow-Up: Sarcoidosis or Not?

2013 · Marie Lequoy, Romain Coriat, et al. · The American Journal of Medicine · 15

NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts

2025 · Josep Amengual, Ester Gonzalez-Sanchez, et al. · Signal Transduction and Targeted Therapy · 14

[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study

2025 · Jean-Charles Nault, Marouane Boubaya, et al. · The Lancet. Gastroenterology & hepatology · 14

Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia

2016 · Aurélie Sannier, Julien Cazejust, et al. · Liver International · 13

No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC

2024 · Francisca‐Dora Copil, Claudia Campani, et al. · Liver International · 12

PDF

Selective internal radiation therapy for unresectable HCC: The SIRT downstaging study

2024 · Hélène Regnault, Julia Chalaye, et al. · Hepatology Communications · 10

Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area

2020 · Aymeric Becq, Benedicte Jais, et al. · Clinics and Research in Hepatology and Gastroenterology · 10

Brain metastases from pancreatic adenocarcinoma: Figure 1

2009 · Aziz Zaanan, Marie Lequoy, et al. · BMJ Case Reports · 10

Real‐World Outcomes of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort

2025 · Manon Allaire, Elhadji Malick Thiam, et al. · Liver International · 9

Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms

2020 · Marie Lequoy, Elia Gigante, et al. · Hormone Molecular Biology and Clinical Investigation · 9

PDF

Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin

2016 · Corina Buta, Eva Benabou, et al. · Journal of Experimental & Clinical Cancer Research · 9

PDF

Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study

2025 · Iona Campo-Le-Brun, Emma Grapinet, et al. · European Journal of Cancer · 7

Works count: 83

Citation count: 1,072

H-index: 14

I10-index: 21